Involving 152 patients, the SENTINEL trial aims to cut lung transplant rejection by up to 50%
Involving 152 patients, the SENTINEL trial aims to cut lung transplant rejection by up to 50%
Both will develop cancer vaccine candidates in selected haematological and solid tumour indications
The Tyche model could help clinicians and researchers capture crucial information in images
Breast cancer was responsible for 2.3 million diagnoses and 670,000 deaths globally in 2022
Both companies will facilitate career progression while advancing the life sciences industry
The findings suggest why children tend to experience milder symptoms compared to older adults
Liver cirrhosis, caused by long-term liver damage, is estimated to affect around 100 million people worldwide
Solid organ transplantation is used to treat end-stage organ failure, including the kidneys
Affecting over 500,000 people in the UK, IBD comprises Crohn’s disease and ulcerative colitis
Approximately 14% of the competition-submitted proposals were selected to receive funding
Both partners’ will leverage their nuclear research facilities and expertise to develop new health interventions
NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases
RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men
The most common form of cancer in men is responsible for 12,000 deaths every year in the UK